GENDER ASPECTS OF CARDIOVASCULAR RISK FACTORS AND EXPECTED LENGTH OF LIFE
DOI:
https://doi.org/10.11603/1681-2786.2020.4.11917Keywords:
men, women, cardiovascular risk factorAbstract
Purpose: to optimize the provision of medical care considering gender aspects on the basis of studying the features of risk factors for cardiovascular diseases.
Materials and Methods. Bibliosemantic and analytical methods were used to in-depth study of gender characteristics of risk factors for cardiovascular diseases.
Results. It is believed that cardiovascular disease mainly affects men, and for women the main threat is cancer. Actually, heart disease affects women more and is much more common than all forms of cancer combined. And this is a fact that today, unfortunately, is unknown to the general public. In the overall structure of mortality, almost half of all deaths are cardiovascular diseases, of which 49 % – in women and 40 % – in men. The common belief that women have less risk factors for developing this pathology is also wrong. The results of many studies have shown that risk factors in women and men have many gender characteristics and differences that must be considered in the diagnostics and treatment of cardiovascular pathology by general practitioners and cardiologists. It is known that most patients of both sexes with risk factors lead an unhealthy lifestyle, don`t reach the target values of blood pressure, lipid and glycemic profiles, which affects the duration and quality of life.
Conclusions. As part of the general strategy to combat the mortality of the population, in particular the working age, from diseases of the circulatory system, a special strategy to combat overall mortality from this cause should be developed and it should become a priority.
References
Zhulkevych, I.V., & Kryvokulskyi, B.D. (2018). Personalizatsiia v onkolohii: indyvidualnyi pidkhid do profilaktyky tromboembolichnykh uskladnen pry panhisterektomii [Personalization in oncology: individual approach to the prevention of thromboembolic complications during hysterectomy]. Visnyk sotsialnoi hihiieny ta orhanizatsii okhorony zdorovia Ukrainy – Bulletin of Social Hygiene and Health Protection Organization of Ukraine, 4, 11-18. Retrieved from: https://doi.org/10.11603/1681-2786.2018.4.9875 [in Ukrainian].
Kovalenko, V.M., & Kornatsky, V.M. (2013). Rehionalni medyko-sotsialni problemy khvorob systemy krovoobihu. Dynamika ta analiz [Regional medical and social problems of diseases of the circulatory system. Dynamics and analysis]. Кyiv [in Ukrainian].
Pasyechko, N.V., Radetska, L.V., Yarema, N.I., Bob, A.O., Smatchylo, I.V., & Homitska, A.I. (2019). Komplaiens do likuvannia khvorykh z arterialnoiu hipertenziieiu ta ishemichnoiu khvoroboiu sertsia v ambulatornykh umovakh [Compliance for the treatment of patients with arterial hypertension and coronary heart disease in outpatient care]. Zdobudky klinichnoi ta eksperymentalnoi medytsyny – Achievements of Clinical and Experimental Medicine, 1, 112-116. Retrieved from: https://doi.org/10.11603/1811-2471.2019.v0.i1.10059 [in Ukrainian].
Yarema, N.I., Pasiechko, N.V., Radetska, L.V., Savchenko, I.P., Bob, A.O., Smachylo, I.V., ..., & Kotsyuba, O.I. (2018). Osoblyvosti perebihu hipertonichnoi khvoroby u zhinok postmenopauzalnoho periodu z porushenniamy mineralnoi shchilnosti kistkovoi tkanyny ta dyslipidemiieiu [Peculiarities of the arterial hypertension in women of postmenopausal period with disturbances of bone mineral density and dyslipidemia]. Visnyk naukovykh doslidzhen – Bulletin of Scientific Research, (3), 53-57. Retrieved from: https://doi.org/10.11603/2415-8798.2018.3.9252 [in Ukrainian].
Shved, N.I., Bakaliuk, O.I., & Zhulkevich, I.V. (1993). Pat. SU 1811376 A 3 A 61 V 5/02. Sposob prognozirovaniya iskhodov ostrogo infarkta miokarda [Pat. SU 1811376 А 3 А 61 В 5/02. A method for predicting the outcomes of acute myocardial infarction]; zayavitel i patentoobladatel Ternopolskiy gosudarstvennyy meditsinskiy institut. No 4899556/14, zayavl. 03.01.1991, opubl. 23.04.1993. Byul. No. 15 [in Russian].
Pokaznyky chyselnosti naselennia Ukrainy. Derzhavna sluzhba statystyky Ukrainy (Derzhstat) [Population indicators of Ukraine. State Statistics Service of Ukraine (Gosstat)]. Retrieved from: http://www.ukrstat.gov.ua [in Ukrainian].
Bakaliuk, O.Y., Shved, M.I., Vanat, I.M., & Zhulkevych, I.V. (1992). Prohrama realizatsii alhorytmu dyferentsiinoi diahnostyky dyslipoproteinemiy dlia skryninhovykh ta klinichnykh doslidzhen [Program for implementation of algorithm for differential diagnosis of dyslipoproteinemias for screening and clinical studies]. IV Konhres svitovoi Federatsii ukrainskykh likarskykh tovarystv – IV Congress of the World Federation of Ukrainian Medical Societies. Kharkiv [in Ukrainian].
(2017). Shchorichna dopovid pro stan zdorovia naselennia, sanitarno-epidemichnu sytuatsiiu ta rezultaty diialnosti systemy okhorony zdorovia Ukrainy. MOZ Ukrainy, DU “UISD MOZ Ukrainy” 2016 rik [Annual report on the state of health of the population, sanitary and epidemiological situation and the results of the health care system of Ukraine 2016. Ministry of Health of Ukraine, State Institution “UISD of the Ministry of Health of Ukraine”]. Kyiv [in Ukrainian].
Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., …, & Wood, D.A. (2013). 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart. J., 34, 28, 2159-2219.
Zhand, C., Rexrode, K.M., Van Dam, R.M., Li., T.Y., & Hu, F.B. (2008). Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation, 117, 1658-1667.
Mansur, A.P., Gomes, E.P., Avakian, S.D., Favarato, D., César, L.A.M., Aldrighi, J.M., & Ramires, J.A.F. (2001). Clustering of traditional risk factors and precocity of coronary disease in women. Int. J. Cardiology., 81, 2-3, 205-209.
Tunstall-Pedoe, H., Kuulasma, K., Mahonen, M., Tolonen, H., Ruokokoski, E., & Amouyel, P. (1999). Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet, 353, 1547-1557.
Vaccarino, V., Johnson, B., Sheps, D., Reis, S.E., Kelsey, S.F., Bittner, V., …, & Noel Bairey Merz, C. (2007). Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: The National heart, lung, and blood Institute – sponsored WISE study. J. Am. Coll. Cardiol., 50, 2044-2050.
Franklin, S.S., Larson, M.G., Khan, S.A., Wong, N.D., Leip, E.P., Kannel, W.B., & Levy, D. (2001). Des the relation of blood pressure to coronary heart disease risk change with aging? Circulation, 103, 1245-1249.
Dickstein, K., & Kjekshus, J. (2002). Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan. Lancet, 360, 752-760.
Wassertheil-Smoller, S., Hendrix, S.L., Limacher, M., Heiss, G., Kooperberg, C., Baird, A., …, & Mysiw, W.J. (2003). Effects of estrogen plus progestin on stroke in postmenopausal women: the Women’s Health Initiative: a randomized trial. JAMA, 289, 2673-2684.
Wilkins, E., Wilson, L., Wickramasinghe, K., Bhatnagar, P., Leal, J., Luengo-Fernandez, R., ..., & Townsend, N. (2017). European Cardiovascular Disease Statistics 2017. European Heart Network, Brussels. Retrieved from: http://www.ehnheart.org/images/CVD-statistics-report-August-2017.pdf.
Mosca, L., Appel, L.J., Benjamin, E.J., Berra, K., Chandra-Strobos, N., Fabunmi, R.P., …, & Williams, C.L. (2004). Evidence-based guidelines for cardiovascular disease prevention in women. J. Am. Coll. Cardiol., 109, 672-692.
Kearney, P.M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P.K., He, J. (2005). Global burden of hypertension: analysis of worldwide data. Lancet, 365, 217-223.
Hong, S., Friedman, J., & Alt, S. (2003). Modifiable risk factors for the primary prevention of heart disease in women. J. Am. Med. Womens Assoc., 58 (4), 278-284.
Kotseva, K., De Backer, G., De Bacquer, D., Rydén, L., Hoes, A., Grobbee, D., …, & Wood, D. (2019). Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur. J. Prev. Cardiol., 26, 8, 824-835.
Mosca, L. (2002). Epidemiology and prevention of heart disease. Cardiovascular health and disease in women. P. S. Douglas ed. 2nd ed. New York: WB Saunders.
Nguyen, V., & McLaughlin, M. (2002). Coronary artery disease in women: a review of emerging cardiovascular risk factors. Mt. Sinai J. Med., 69, 338-349.
Office on Smoking and Health (US) (2001). Women and smoking: a report of the surgeon general. Atlanta (GA): Centers for disease control and prevention (US).
Mosca, L., Merz, N.B., Blumenthal, R.S., Cziraky, M.J., Fabunmi, R.P., Sarawate, C., …, & Stanek, E.J. (2005). Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a manages care setting. Circulation, 111, 488-493.
Pettee, K.K., Kriska, A.M., & Johnson, B.D. (2007). The relationship between physical activity and lipoprotein subclasses in postmenopausal women: the influence of hormone therapy. Menopause, 14, 115-122.
Lloyd-Jones, D.M., Leip, E.P., Larson, M.G., D’Agostino, R.B., Beiser, A., Wilson, P.W.F., …, & Levy, D. (2006). Prediction of lifeime risk for cardiovascular dieses by risk factor burden at 50 years of age. Circulation, 113, 791-798.
Almgren T., Persson B., Wilhelmsen, L., Rosengren, A., & Andersson, O.K. (2005). Stroke and coronary heart disease in treated hypertension: a prospective cohort study over three decades. J. Intern. Med., 257, 496-502.
Mykhailovska, N.S., Stetsiuk, I.O., Kulynych, T.O., Gorbachova, S.V., & Zhulkevych, I.V. (2020). The interrelationship of bone and cardiovascular remodeling biomarkers and clinical peculiarities of coronary artery disease in postmenopausal women. Reumatologia, 58 (3), 142-149.
Sturdee, D.W., Pines, A., Archer, D.F., Baber, R.J., Barlow, D., Birkhäuser, M.H., …, & Stevenson, J.C. (2011). Updated IMS Recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric, 14, 302-320.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Bulletin of Social Hygiene and Health Protection Organization of Ukraine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).
